Lipopolysaccharide Binding Protein (LBP) (Middle Region) Peptide
LBP
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all LBP products
- LBP (Lipopolysaccharide Binding Protein (LBP))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-LBP antibody (Catalog #: ARP41545_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- LBP (Lipopolysaccharide Binding Protein (LBP))
- Synonyms
- BPIFD2 Peptide, Bpifd2 Peptide, Ly88 Peptide, LPSBP Peptide, LBP Peptide, lipopolysaccharide binding protein Peptide, lipopolysaccharide-binding protein Peptide, LBP Peptide, Lbp Peptide, LOC100472839 Peptide
- Background
-
LBP is involved in the acute-phase immunologic response to gram-negative bacterial infections. Gram-negative bacteria contain a glycolipid, lipopolysaccharide (LPS), on their outer cell wall. Together with bactericidal permeability-increasing protein (BPI
Alias Symbols: MGC22233, BPIFD2
Protein Interaction Partner: APOA1,CAMP,CD14,CFHR1,RPS21,APOA1,CD14,CFHR1,IRF6
Protein Size: 481 - Molecular Weight
- 51 kDa
- Gene ID
- 3929
- NCBI Accession
- NM_004139, NP_004130
- UniProt
- P18428
-
You are here:
